Avalo Therapeutics (AVTX) Payables (2014 - 2026)
Avalo Therapeutics (AVTX) reported Payables of $356000.0 for Q1 2026, down 47.72% on a YoY basis from $681000.0 in Q1 2025, and up 159.85% quarter-over-quarter from $137000.0 in Q4 2025.
Avalo Therapeutics (AVTX) Payables (2014 - 2026) Analysis & Trends
Avalo Therapeutics has reported Payables for 13 years, with the latest figure at $356000.0 in Q1 2026.
- For the quarter ending Q1 2026, Payables fell 47.72% year-over-year to $356000.0; the trailing twelve-month figure through Mar 2026 stood at $356000.0 (down 47.72% YoY), and the FY2025 full-year result was $137000.0, down 51.59% from the prior year.
- Payables for Q1 2026 stood at $356000.0, up from $137000.0 in the prior quarter.
- The five-year high for Payables was $36.9 million in Q1 2022, with the low at $137000.0 in Q4 2025.
- Historically, Payables has averaged $5.3 million across 5 years, with a median of $916000.0 in 2024.
- Annual changes were most pronounced in 2023 — Payables soared 586.97% — and 2024, when it plunged 95.6%.
- Avalo Therapeutics' Payables stood at $8.8 million in 2022, then sank by 94.94% to $446000.0 in 2023, then slumped by 36.55% to $283000.0 in 2024, then slumped by 51.59% to $137000.0 in 2025, then jumped by 159.85% to $356000.0 in 2026.
- The last three Payables figures came in at $356000.0 (Q1 2026), $137000.0 (Q4 2025), and $474000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Avalo Therapeutics | 295.77 Mn | 295.77 Mn | - | 356,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 356,000.00 |
| Dec 31, 2025 | 137,000.00 |
| Sep 30, 2025 | 474,000.00 |
| Jun 30, 2025 | 2.37 Mn |
| Mar 31, 2025 | 681,000.00 |
| Dec 31, 2024 | 283,000.00 |
| Sep 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 654,000.00 |
| Mar 31, 2024 | 916,000.00 |
| Dec 31, 2023 | 446,000.00 |
| Sep 30, 2023 | 789,000.00 |
| Jun 30, 2023 | 14.87 Mn |
| Mar 31, 2023 | 14.86 Mn |
| Dec 31, 2022 | 8.81 Mn |
| Sep 30, 2022 | 4.01 Mn |
| Jun 30, 2022 | 2.16 Mn |
| Mar 31, 2022 | 36.94 Mn |
| Dec 31, 2021 | 3.37 Mn |
| Sep 30, 2021 | 36.05 Mn |
| Jun 30, 2021 | 21.11 Mn |